The Blog Lives On!

Learning doesn’t have to end just because the 2017 AABB Annual Meeting is over. We will continue to add blog posts about sessions for the next week or two. Bookmark this page and you can check back easily and often to see what’s new on the blog. Upcoming posts will discuss sessions on starting a … Continue reading “The Blog Lives On!”

Iron Supplementation for Blood Donors a Key Topic at AABB 2017

  Iron supplementation is one of the most talked-about topics in the field of transfusion medicine these days. So it’s no surprise that the Tuesday morning session on this issue included a variety of strong opinions and thought-provoking data. The session, “Iron Supplementation in Blood Donors: Who, What Why and How?,” featured four experts – … Continue reading “Iron Supplementation for Blood Donors a Key Topic at AABB 2017”

Old Blood? New Blood? Is it the End of the Beginning of the Storage Lesion?

The debate over old versus new blood is older than, well, the longest stored blood.

The debate over old versus new blood is older than, well, the longest stored blood.

Tracking TRALI Risk in Transgender Donors; Assessing 1-Year Deferral Change for MSM Donors

One of the more vexing questions facing blood collection facilities is how to assess anti-HLA antibodies in transgender donors to minimize TRALI risk. Researchers at the American Red Cross (ARC) presented data on the risk of failing to ask transgender (TG) males (birth gender female) about pregnancy. TG males may have had prior pregnancies or … Continue reading “Tracking TRALI Risk in Transgender Donors; Assessing 1-Year Deferral Change for MSM Donors”

Missed the Plenary Scientific Oral Abstracts? Here’s a Quick Rundown

Iron status in diverse donor population Data from the Red Blood Cell-Omics (RBC-Omics) study suggest that African American and Asian blood donors may be less likely to have lower levels of iron stores compared with non-Hispanic white donors, while Hispanic donors appear to have a greater risk for low iron, lead author lead author Bryan … Continue reading “Missed the Plenary Scientific Oral Abstracts? Here’s a Quick Rundown”

INFORM: No Difference in Mortality Seen with Exposure to “Oldest” Old Blood vs. Freshest

More evidence for the safety of older RBCs comes from a pre-specified exploratory analysis of data from the nearly 25,000-patient INFORM trial. The researchers found no significant difference in in-hospital mortality (hazard ratio, 0.92) between patients given blood with a median age of 36-42 days old versus those receiving median-aged blood of 7 days or … Continue reading “INFORM: No Difference in Mortality Seen with Exposure to “Oldest” Old Blood vs. Freshest”

Martin Olsson Receives Tibor Greenwalt Memorial Award

Martin Olsson received the 2017 Tibor Greenwalt Memorial Award for outstanding achievements in molecular genetics of red-cell surface antigens.

Martin Olsson received the 2017 Tibor Greenwalt Memorial Award for outstanding achievements in molecular genetics of red-cell surface antigens.

2017 Emily Cooley Award Goes to Dennis Goldfinger

“You can’t get CMV from a blood transfusion.” Dennis Goldfinger, MD, winner of the 2017 Emily Cooley Memorial Award began his lecture on “Establishing Standards of Care: Ridding Ourselves of Faulty Notions and Bad Science” with these words. Goldfinger earned the Cooley Award for his work pioneering the first hospital-based blood center in California in … Continue reading “2017 Emily Cooley Award Goes to Dennis Goldfinger”

Sally Frank Memorial Award Honors Pioneer in Immunohematology

Greg Denomme, PhD, FCSMLS(D), received the Sally Frank Memorial Award and Lectureship for his lifelong achievements in platelet- and RBC-immunohematology, pathobiology and molecular diagnostics. 

Greg Denomme, PhD, FCSMLS(D), received the Sally Frank Memorial Award and Lectureship for his lifelong achievements in platelet- and RBC-immunohematology, pathobiology and molecular diagnostics.